Vietnam Ponders Ban On Roche’s Avastin For Metastic Breast Cancer
This article was originally published in PharmAsia News
Executive Summary
Vietnam drug authorities said they are considering a ban on Roche’s Avastin (bevacizumab) for treating breast cancer in the wake of U.S. FDA’s similar action.